LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "allo hsct" as a keyword



Photo from wikipedia

The Registry Data Analysis of HSCT on Systemic Chronic Active EBV Infection Patients in Japan.

Sign Up to like & get
recommendations! Published in 2022 at "American journal of hematology"

DOI: 10.1002/ajh.26544

Abstract: The effects of allogeneic hematopoietic stem cell transplantation (allo-HSCT) on systemic chronic active Epstein-Barr virus infection (sCAEBV) are yet to be analyzed in a large number of patients. Using the Japanese registry database, Transplant Registry… read more here.

Keywords: hsct systemic; systemic chronic; hsct; allo hsct ... See more keywords
Photo by ronaldlangeveld from unsplash

Improved survival outcomes and restoration of graft‐vs‐leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia

Sign Up to like & get
recommendations! Published in 2019 at "Cancer Medicine"

DOI: 10.1002/cam4.1928

Abstract: Deferasirox is an oral iron‐chelating agent having possible antileukemia and immune modulatory effects. Few reports have evaluated deferasirox in the setting of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We investigated the impact of deferasirox after… read more here.

Keywords: allo hsct; graft; effect; stem cell ... See more keywords
Photo by nci from unsplash

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation

Sign Up to like & get
recommendations! Published in 2020 at "Cancer Medicine"

DOI: 10.1002/cam4.2865

Abstract: Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML). In this phase 2 study, we treated 18‐ to 65‐year‐old AML patients refractory to first‐line 3 + 7 daunorubicin/cytarabine induction or relapsing after 3 + 7… read more here.

Keywords: allo hsct; relapsed acute; clofarabine; refractory relapsed ... See more keywords
Photo by polarmermaid from unsplash

Combination of KIT and FLT3‐ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission

Sign Up to like & get
recommendations! Published in 2022 at "Hematological Oncology"

DOI: 10.1002/hon.3015

Abstract: Although several studies have investigated the benefits of allogeneic hematopoietic stem cell transplantation (allo‐HSCT) for patients with inv (16) acute myeloid leukemia (AML) in first complete remission (CR1) individually stratified by KIT or FMS‐like tyrosine… read more here.

Keywords: combination; flt3 itd; allo hsct; mutation status ... See more keywords
Photo by kellysikkema from unsplash

DNTT activation, TdT‐aided gene length mutation, and better prognosis in ATG‐based regimen allo‐HSCT in AML

Sign Up to like & get
recommendations! Published in 2023 at "Molecular Carcinogenesis"

DOI: 10.1002/mc.23514

Abstract: This study aimed to investigate the relationship between anomalous DNA nucleotidylexotransferase (DNTT) activation and the mutagenesis of gene length mutations (LMs) in acute myeloid leukemia (AML), and the relevance of their prognosis in antithymocyte globulin… read more here.

Keywords: regimen allo; aml; dntt activation; based regimen ... See more keywords
Photo by kevinjiner from unsplash

Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies

Sign Up to like & get
recommendations! Published in 2018 at "Annals of Hematology"

DOI: 10.1007/s00277-018-3585-1

Abstract: Cytomegalovirus (CMV) infection and primary disease relapse remain challenging problems after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We sought to assess the association between CMV infection and disease relapse after transplantation. PubMed, EMBASE, the Cochrane… read more here.

Keywords: relapse; allo hsct; cmv; disease relapse ... See more keywords
Photo by sammiechaffin from unsplash

Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation

Sign Up to like & get
recommendations! Published in 2017 at "Medical Microbiology and Immunology"

DOI: 10.1007/s00430-017-0511-4

Abstract: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment option for several hematological diseases. However, the first year post-transplantation is often complicated by infections and graft-versus-host disease (GVHD). Improvements in immunological monitoring could reduce… read more here.

Keywords: allo hsct; risk; viremia; transplantation ... See more keywords
Photo by skulkingfaux from unsplash

Oral microorganisms and bloodstream infection in allogeneic hematopoietic stem cell transplantation.

Sign Up to like & get
recommendations! Published in 2021 at "Clinical oral investigations"

DOI: 10.1007/s00784-020-03749-9

Abstract: OBJECTIVES We aimed to compare oral and pathogenic microorganisms in bloodstream infections (BSIs) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). We also investigated the relationship between BSIs and oral mucositis to identify the ratio of… read more here.

Keywords: allo hsct; hsct; microorganisms bloodstream; bsis ... See more keywords
Photo by mostafa_meraji from unsplash

Reduced β2-GPI is associated with increased platelet aggregation and activation in patients with prolonged isolated thrombocytopenia after allo-HSCT

Sign Up to like & get
recommendations! Published in 2018 at "Science China Life Sciences"

DOI: 10.1007/s11427-018-9493-8

Abstract: We aimed to measure platelet function and its relationship with β2-GPI in prolonged isolated thrombocytopenia (PT) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Fifty-six patients with PT and 60 allo-HSCT recipients without PT (non-PT controls)… read more here.

Keywords: allo hsct; aggregation activation; platelet aggregation; gpi ... See more keywords
Photo by sorasagano from unsplash

Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status

Sign Up to like & get
recommendations! Published in 2018 at "International Journal of Hematology"

DOI: 10.1007/s12185-018-2413-7

Abstract: In allogeneic hematopoietic stem cell transplantation (allo-HSCT) from unrelated donors, delays in donor search are adversely associated with patient outcome. However, the optimal duration for either waiting for an unrelated donor or selecting alternative sources… read more here.

Keywords: allo hsct; japan marrow; marrow donor; group ... See more keywords
Photo by morsha from unsplash

[Bone marrow transplant in patients with sickle cell anaemia. Experience in one centre].

Sign Up to like & get
recommendations! Published in 2017 at "Anales de pediatria"

DOI: 10.1016/j.anpedi.2016.03.014

Abstract: INTRODUCTION Sickle cell disease (SCD), despite the improvement in the medical management, is still associated with severe morbidity and decreased survival. Allogenic hematopoietic stem cell transplantation (Allo-HSCT) currently provides the only curative therapy. A report… read more here.

Keywords: allo hsct; centre; transplant; cell ... See more keywords